ATE393148T1 - Neue benzimidazolderivative und ihre pharmazeutische zusammensetzungen - Google Patents
Neue benzimidazolderivative und ihre pharmazeutische zusammensetzungenInfo
- Publication number
- ATE393148T1 ATE393148T1 AT04725384T AT04725384T ATE393148T1 AT E393148 T1 ATE393148 T1 AT E393148T1 AT 04725384 T AT04725384 T AT 04725384T AT 04725384 T AT04725384 T AT 04725384T AT E393148 T1 ATE393148 T1 AT E393148T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compounds
- benzimidazole derivatives
- sub
- new benzimidazole
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000015114 central nervous system disease Diseases 0.000 abstract 2
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- 208000002091 Febrile Seizures Diseases 0.000 abstract 1
- 206010021118 Hypotonia Diseases 0.000 abstract 1
- 206010039897 Sedation Diseases 0.000 abstract 1
- 238000001949 anaesthesia Methods 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036640 muscle relaxation Effects 0.000 abstract 1
- 230000036280 sedation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300557 | 2003-04-10 | ||
| US46179403P | 2003-04-11 | 2003-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE393148T1 true ATE393148T1 (de) | 2008-05-15 |
Family
ID=33160906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04725384T ATE393148T1 (de) | 2003-04-10 | 2004-04-02 | Neue benzimidazolderivative und ihre pharmazeutische zusammensetzungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060241101A1 (de) |
| EP (1) | EP1615896B1 (de) |
| JP (1) | JP2006522773A (de) |
| AT (1) | ATE393148T1 (de) |
| DE (1) | DE602004013299T2 (de) |
| WO (1) | WO2004089912A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006111517A1 (en) * | 2005-04-19 | 2006-10-26 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| GB0616467D0 (en) * | 2006-08-17 | 2006-09-27 | Camrivox Ltd | Network tunnelling |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ334868A (en) * | 1996-10-21 | 2001-02-23 | Neurosearch As | 1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators |
| NZ515543A (en) * | 1999-06-22 | 2003-11-28 | Neurosearch As | Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| AU2002221566A1 (en) * | 2000-12-20 | 2002-07-01 | Neurosearch A/S | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders |
-
2004
- 2004-04-02 JP JP2006505515A patent/JP2006522773A/ja not_active Abandoned
- 2004-04-02 US US10/551,821 patent/US20060241101A1/en not_active Abandoned
- 2004-04-02 AT AT04725384T patent/ATE393148T1/de not_active IP Right Cessation
- 2004-04-02 EP EP04725384A patent/EP1615896B1/de not_active Expired - Lifetime
- 2004-04-02 WO PCT/EP2004/050427 patent/WO2004089912A1/en not_active Ceased
- 2004-04-02 DE DE602004013299T patent/DE602004013299T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1615896A1 (de) | 2006-01-18 |
| EP1615896B1 (de) | 2008-04-23 |
| DE602004013299T2 (de) | 2009-06-25 |
| JP2006522773A (ja) | 2006-10-05 |
| US20060241101A1 (en) | 2006-10-26 |
| WO2004089912A1 (en) | 2004-10-21 |
| DE602004013299D1 (de) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60025604D1 (de) | Benzimidazol-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| EA200601798A1 (ru) | Замещенные соединения морфолина для лечения расстройств центральной нервной системы | |
| MY149855A (en) | Benzimidazole derivatives and their use for modulating the gaba? receptor complex | |
| SE0201635D0 (sv) | Novel compounds | |
| CY1111927T1 (el) | Νεες ενωσεις ως διαμορφωτες υποδοχεα οπιοειδων | |
| UY28374A1 (es) | Agentes terapéuticos | |
| UY28376A1 (es) | Agentes terapéuticos | |
| EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
| EA200600071A1 (ru) | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором | |
| DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
| UY28377A1 (es) | Agentes terapeuticos | |
| IL189974A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора | |
| UY28839A1 (es) | Agentes terapeuticos | |
| WO2004087690A3 (en) | Benzimidazole derivatives and their use for modulating the gaba-a receptor complex | |
| EA200870074A1 (ru) | Производные 4,5-дигидро-(1н)-пиразола в качестве модуляторов каннабиноидного рецептора св1 | |
| ATE386519T1 (de) | Benzimidazole derivate und ihre anwendung als gaba a rezeptor komplex modulatoren | |
| EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении | |
| DE602004013299D1 (de) | Neue benzimidazolderivative und ihre pharmazeutische zusammensetzungen | |
| WO2007042544A3 (en) | Imidazole derivatives and their use for modulating the gabaa receptor complex | |
| WO2002050057A8 (en) | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders | |
| MX2007012624A (es) | Derivados de benzimidazol y su uso para la modulacion del complejo del receptor gaba-a. | |
| EA200701758A1 (ru) | Замещённые арильные производные 1,4-пиразина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |